The Vaccine Inequity Dilemma

This chapter scrutinizes the ethical implications of COVID-19 vaccine distribution, focusing on the profit-driven motives of pharmaceutical companies like Moderna and the political failures that exacerbate global inequity. It highlights efforts in South Africa to increase vaccine access and calls for collaboration and policy changes to address the challenges posed by patent protections and vaccine hoarding.